11/30/2021, 2:22 PM (Source: TeleTrader)
more TeleTrader news

Pfizer vaccine executive to join GSK

Philip Dormitzer, who was one of the executives involved in the development of Pfizer Inc.'s coronavirus vaccine, is set to join GlaxoSmithKline plc (GSK) as global head of vaccines research and development.

Dormitzer helped Pfizer create the partnership with BioNTech SE that lead to the COVID vaccine, as well as leading the company's United States viral vaccine portfolio. He also oversaw the development of some vaccines at Pfizer that are in direct competition with GSK.

GSK Chief Scientific Officer Hal Barron welcomed the new appointment, saying that he was "delighted with Dormitzer's significant experience in mRNA technologies."

Baha Breaking News (BBN) / OL